Clinical trial
Nasal Continuous Positive Airway Pressure Versus Non-invasive Positive Pressure Ventilation as Primary Support Before Minimally Invasive Surfactant Administration for Preterm Infants With NRDS
NCT05137340 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nasal Continuous Positive Airway Pressure Versus Non-invasive Positive Pressure Ventilation as Primary Support Before Minimally Invasive Surfactant Administration for Preterm Infants With NRDS
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 1, 2021
- Completion date
- March 10, 2025
- Enrollment
- 312 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
minimal invasive surfactant administration in two different non-invasive ventilation modes to nrds infants